- Continuing Quality Assessment Program Improves Clinical Outcomes of Hospitalized Community-Acquired Pneumonia: A Nationwide CrossSectional Study in Korea
-
An TJ, Myong JP, Lee YH, Kwon SO, Shim EK, Shin JH, Yoon HK, Jeong SH
- KMID: 2532228
- J Korean Med Sci.
- 2022 Aug;37(30):e234.
- doi: 10.3346/jkms.2022.37.e234
Background: Pneumonia, which is the third leading cause of death in South Korea, is continuously increasing with the aging society. The Health Insurance Review and Assessment of South Korea conducted... -
- CITED
-
- Close
- SHARE
-
- Close
- Beta-Lactam Plus Macrolide for Patients Hospitalized With CommunityAcquired Pneumonia: Difference Between Autumn and Spring
-
Kim Y, Jeon Y, Kwon KT, Bae S, Hwang S, Chang HH, Kim SW, Lee WK, Yang KH, Shin JH, Shim EK
- KMID: 2536129
- J Korean Med Sci.
- 2022 Nov;37(45):e324.
- doi: 10.3346/jkms.2022.37.e324
Background: The 2017 Korean guideline on community-acquired pneumonia (CAP) recommended beta-lactam plus macrolide combination therapy for patients hospitalized with severe pneumonia, and beta-lactam monotherapy for mild-to-moderate pneumonia. However, antibiotic treatment regimen... -
- CITED
-
- Close
- SHARE
-
- Close
